{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:58:11Z","timestamp":1783486691510,"version":"3.55.0"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej15-0637","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T22:05:51Z","timestamp":1449007551000},"page":"323-328","source":"Crossref","is-referenced-by-count":32,"title":["Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review]"],"prefix":"10.1507","volume":"63","author":[{"given":"Yasuhiro","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ito Y, Miyauchi A (2007) A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. <i>Nat Clin Pract Endocrin Metab<\/i> 3: 240-248.","DOI":"10.1038\/ncpendmet0428"},{"key":"2","unstructured":"2. Takebe K, Date M, Yamamoto Y (1994) Mass screening for thyroid cancer with ultrasonography (in Japanese). <i>KARKINOS<\/i> 7: 309-317."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ito Y, Uruno R, Nakano K, Takamura Y, Miya A, et al. (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. <i>Thyroid<\/i> 13: 381-388.","DOI":"10.1089\/105072503321669875"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sugitani I, Koda K, Yamada K, Yamamoto N, Ikenaga M, et al. (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. <i>World J Surg<\/i> 34: 1222-1231.","DOI":"10.1007\/s00268-009-0359-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, et al. (2010) An observation trial for papillary thyroid microcarcinoma in Japanese patients. <i>World J Surg<\/i> 34: 28-35.","DOI":"10.1007\/s00268-009-0303-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, et al. (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. <i>Thyroid<\/i> 24: 27-34.","DOI":"10.1089\/thy.2013.0367"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sugitani I, Fujimoto Y, Yamada K (2014) Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. <i>World J Surg<\/i> 38: 673-378.","DOI":"10.1007\/s00268-013-2335-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fukuoka O, Sugitani I, Ebina A, Toda K, Kawabata K, et al. (2016) Natural history of asymptomatic papillary thyroid microcarcinoma: Time-Dependent changes in calcification and vascularity during active surveillance. <i>World J Surg<\/i> 40: 529-537.","DOI":"10.1007\/s00268-015-3349-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito Y, Miyauchi A, Oda H, Kobayashi K, Kihara M, et al. (2016) Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? <i>World J Surg <\/i>40: 523-528.","DOI":"10.1007\/s00268-015-3184-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the Unites States, 1973-2002. <i>JAMA <\/i>595: 2164-2167.","DOI":"10.1001\/jama.295.18.2164"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. <i>JAMA Otolaryngol Head Neck Surg<\/i> 140: 317-322.","DOI":"10.1001\/jamaoto.2014.1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ahn HS, Kim HJ, Welch HG (2014) Korea&rsquo;s thyroid-cancer &ldquo;epidemic&rdquo; &mdash; screening and overdiagnosis. <i>N Engl J Med<\/i> 371: 1765-1767.","DOI":"10.1056\/NEJMp1409841"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Uruno T, Miyauchi A, Shimizu K, Tomoda C, Takamura Y, et al. (2005) Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. <i>World J Surg<\/i> 29: 483-485.","DOI":"10.1007\/s00268-004-7701-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. <i>Thyroid<\/i> 26: 1-133.","DOI":"10.1089\/thy.2015.0020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Liu X, Bishop J, Shan Y, Pai S, Liu D, et al. (2013) Highly prevalent <i>TERT<\/i> promoter mutations in aggressive thyroid cancers. <i>Endocr Relat Cancer<\/i> 20: 603-610.","DOI":"10.1530\/ERC-13-0210"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Xing M, Liu B, Liu X, Murgan AK, Zhu G, et al. (2014) <i>BRAFV600E<\/i> and <i>TERT<\/i> promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. <i>J Clin Oncol<\/i> 32: 2716-2726.","DOI":"10.1200\/JCO.2014.55.5094"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ito Y, Yoshida H, Maruo R, Morita S, Takano T, et al. (2009) BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. <i>Endocr J<\/i> 56: 89-97.","DOI":"10.1507\/endocrj.K08E-208"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ito Y, Yoshida H, Kihara M, Kobayashi K, Miya A, et al. (2014) BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients? <i>World J Surg<\/i> 38: 679-687.","DOI":"10.1007\/s00268-013-2223-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sugitani I, Fujimoto Y (2010) Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. <i>J Clin Endocrinol Metab<\/i> 95: 4576-4583.","DOI":"10.1210\/jc.2010-0161"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, et al. (2014) Papillary thyroid microcarcinoma might progress during pregnancy. <i>Thyroid <\/i>24: 840-844.","DOI":"10.1089\/thy.2013.0527"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ito Y, Miyauchi A, Kudo T, Ota H, Yoshioka K, et al. (2016) Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital. <i>Thyroid<\/i> 26: 156-160.","DOI":"10.1089\/thy.2015.0393"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, et al. (2016) Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. <i>Thyroid<\/i> 26: 150-155.","DOI":"10.1089\/thy.2015.0313"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lim CY, Yun JS, Lee J, Nam KH, Chung WY, et al. (2007) Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. <i>Thyroid <\/i>17: 347-350.","DOI":"10.1089\/thy.2006.0251"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dupuy DE, Monchik JM, Decrea C, Pisharodi L (2001) Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. <i>Surgery<\/i> 130: 971-977.","DOI":"10.1067\/msy.2001.118708"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/4\/63_EJ15-0637\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:49:56Z","timestamp":1498265396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/4\/63_EJ15-0637\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0637","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}